Academic Journal
Prospects for the use of anti-inflammatory therapy in patients with coronary artery disease
| العنوان: | Prospects for the use of anti-inflammatory therapy in patients with coronary artery disease |
|---|---|
| المؤلفون: | N. M. Abduzhamalova, M. N. Mamedov |
| المصدر: | Рациональная фармакотерапия в кардиологии, Vol 20, Iss 5, Pp 550-558 (2024) |
| بيانات النشر: | Столичная издательская компания, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Therapeutics. Pharmacology LCC:Diseases of the circulatory (Cardiovascular) system |
| مصطلحات موضوعية: | atherosclerosis, anti-inflammatory drugs, inflammation, nlrp3 inflammasome, colchicine, canakinumab, methotrexate, coronary artery disease, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701 |
| الوصف: | Coronary atherosclerosis is the primary cause of coronary artery disease, one of the world’s greatest causes of death. Inflammation plays a major role in atherosclerosis formation and progression. Cardiovascular disease risk factors such as dyslipidemia, hyperglycemia, smoking, hypertension and others contribute to endothelial injury. This sets off a cascade of inflammatory reactions accompanied by the release of cytokines and other inflammatory mediators, ultimately leading to rupture or erosion of the atherosclerotic plaque and atherothrombosis. Large studies such as CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study); COLCOT (Colchicine Cardiovascular Outcomes Trial) and LoDoCo2 (Low Dose Colchicine 2) demonstrated that the use of anti-inflammatory drugs improves the prognosis of patients with coronary atherosclerosis. At present, the most convincing evidence of the effectiveness of anti-inflammatory therapy was obtained only for colchicine and canakinumab. However, despite these promising results, there are still many issues to be addressed. Firstly, more research is needed to determine the optimal dosage and duration of these drugs. Secondly, the safety of their prolonged use should be carefully assessed, especially in the context of possible side effects. For example, anti-inflammatory drugs can potentially pose infectious risks that require special monitoring and follow-up. The review presents current views on the possibilities immunomodulatory drugs using in the complex treatment of atherosclerosis. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English Russian |
| تدمد: | 1819-6446 2225-3653 |
| Relation: | https://www.rpcardio.online/jour/article/view/3105; https://doaj.org/toc/1819-6446; https://doaj.org/toc/2225-3653 |
| DOI: | 10.20996/1819-6446-2024-3105 |
| URL الوصول: | https://doaj.org/article/78554945377440c3a46d4b702e17e1a6 |
| رقم الانضمام: | edsdoj.78554945377440c3a46d4b702e17e1a6 |
| قاعدة البيانات: | Directory of Open Access Journals |
| تدمد: | 18196446 22253653 |
|---|---|
| DOI: | 10.20996/1819-6446-2024-3105 |